199 related articles for article (PubMed ID: 25754799)
1. Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mapping.
Radmard AR; Poustchi H; Dadgostar M; Yoonessi A; Kooraki S; Jafari E; Hashemi Taheri AP; Malekzadeh R; Merat S
Acad Radiol; 2015 Jun; 22(6):714-21. PubMed ID: 25754799
[TBL] [Abstract][Full Text] [Related]
2. Central Obesity and Liver Iron Content: A Noninvasive Assessment in General Population by Magnetic Resonance Imaging.
Radmard AR; Poustchi H; Hashemi Taheri AP; Gerami Seresht M; Mohammadinejad P; Yoonessi A; Dadgostar M; Rahmanian MS; Jafari E; Zeinoddini A; Malekzadeh R; Merat S
Ann Nutr Metab; 2016; 69(3-4):181-189. PubMed ID: 27855393
[TBL] [Abstract][Full Text] [Related]
3. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
4. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
5. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
[TBL] [Abstract][Full Text] [Related]
7. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Differential Diagnosis of Liver Iron Contents in Nonalcoholic Steatohepatitis and Simple Steatosis Using Multiecho Dixon Magnetic Resonance Imaging.
Kim TH; Jeong CW; Jun HY; Kim YR; Kim JY; Lee YH; Yoon KH
Acad Radiol; 2019 Jun; 26(6):766-774. PubMed ID: 30143402
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Abdominal Fat Distribution in Non-Alcoholic Fatty Liver Disease by Magnetic Resonance Imaging: a Population-based Study.
Radmard AR; Rahmanian MS; Abrishami A; Yoonessi A; Kooraki S; Dadgostar M; Hashemi Taheri AP; Gerami Seresht M; Poustchi H; Jafari E; Malekzadeh R; Merat S
Arch Iran Med; 2016 Oct; 19(10):693-699. PubMed ID: 27743433
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
[TBL] [Abstract][Full Text] [Related]
12. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Sung KC; Ryan MC; Wilson AM
Atherosclerosis; 2009 Apr; 203(2):581-6. PubMed ID: 18774133
[TBL] [Abstract][Full Text] [Related]
13. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
15. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults.
Umehara T
PLoS One; 2018; 13(6):e0197900. PubMed ID: 29897928
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
[TBL] [Abstract][Full Text] [Related]
19. γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.
Pei D; Hsia TL; Chao TT; Lin JD; Hsu CH; Wu CZ; Hsieh CH; Liang YJ; Chen YL
Saudi J Gastroenterol; 2015; 21(3):158-64. PubMed ID: 26021775
[TBL] [Abstract][Full Text] [Related]
20. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.
Bi WR; Yang CQ; Shi Q; Xu Y; Cao CP; Ling J; Wang XY
Genet Mol Res; 2014 Aug; 13(3):5880-91. PubMed ID: 25117346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
